About 180 people will get MRI scans while making food and money choices through March 2027. Noom is funding the work led by neuroscientist Michael Platt.
Recap by typeshit. Full story at CBS News.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Texas A&M Medicine says the wider use of GLP-1 drugs is changing how people talk about body image, weight stigma and self-worth.
Feller urges people on GLP-1s to work with a registered dietitian and their provider so they keep getting enough nutrients while losing weight.
Loading…